Fight The Fakes

Speak up about fake medicines.

Campaign Updates

IFPMA and FIP deliver statements at the WHO Executive Board


IFPMA and FIP deliver statements at the WHO Executive Board

The World Health Organization and its member states have identified substandard/spurious/falsely-labelled/falsified/counterfeit (SSFFC) medical products as a serious threat to patients and public health.

SSFFC medicinal products were discussed today by the WHO Executive Board and its member states. Fight the Fakes is pleased to announce that partners FIP and IFPMA made statements on the issue of falsified medicines and the need for joint, coordinated effort.

FIP praised initiatives from governments and public and private sectors in tackling fake medicines. However, it called for further coordination and consistency at both local and international level. FIP’s statement was supported by partner WHPA.

IFPMA highlighted the key role of education and knowledge as a means to increase awareness of the subject. In addition, IFPMA paid tribute to Fight the Fakes for the campaign’s work in this area. IFPMA also welcomed the WHO’s decision to accept the term ‘falsified’ in regards to fake medicines.

Both IFPMA and FIP statements can be found here:

blog comments powered by Disqus

Back to List

🗣️Reporting is crucial to find how many #fakemeds are out there 💊 Learn more ->

#Fakemeds put patients at risk of further illness, disability or even death ❗️ Read more on

Monitoring and reporting are important to fight #fakemeds. Help @FightTheFakes & spread the word!

Antimalarials are among the most commonly reported #fakemeds ❗️ Stay safe and speak up against falsified medicines! 🗣️

A study in 10 sub-Saharan #African 🌍 countries found heart-breaking 💔 data about #fakemeds